Acta Chimica Sinica ›› 2022, Vol. 80 ›› Issue (4): 563-569.DOI: 10.6023/A21120602 Previous Articles     Next Articles

Special Issue: 中国科学院青年创新促进会合辑

Review

药物化学中的大分子效应

赵佳雨a,b, 宋万通a,c,*(), 汤朝晖a,b,c, 陈学思a,b,c   

  1. a 中国科学院长春应用化学研究所 中国科学院生态环境高分子材料重点实验室 长春 130022
    b 中国科学技术大学 合肥 230026
    c 吉林省生物医用高分子材料工程实验室 长春 130022
  • 投稿日期:2021-12-30 发布日期:2022-04-28
  • 通讯作者: 宋万通
  • 作者简介:

    赵佳雨, 2017年至今博士就读于中国科学院长春应用化学研究所, 高分子化学与物理专业, 主要从事于高分子免疫刺激材料应用于抗肿瘤疫苗设计的研究.

    宋万通, 中国科学院长春应用化学研究所研究员. 2008年本科毕业于南京大学, 2013年于中国科学院长春应用化学研究所取得博士学位(导师陈学思院士), 2016~2018年赴美国北卡罗来纳大学教堂山分校药学院进行博士后研究(导师Leaf Huang教授). 主要从事高分子疫苗载体与肿瘤免疫治疗方向的研究工作. 先后以第一/通讯作者在Nat. Nanotechnol., Nat. Commun., Adv. Mater., ACS Nano, Nano Lett., Biomaterials等杂志发表研究及综述论文60余篇.

    汤朝晖, 中国科学院长春应用化学研究所研究员, 博士生导师. 曾在英国帝国理工学院和美国纽约州立大学石溪分校做博士后. 主要从事高分子载体抗肿瘤纳米药物研究. 在Adv. Mater., Adv. Sci., Prog. Polym. Sci., Chem. Sci., Biomaterials, J. Control. Release等知名期刊发表学术论文100余篇.

    陈学思, 中国科学院院士, 中国科学院长春应用化学研究所研究员、博士生导师, 中国科学院生态环境高分子材料重点实验室学委会副主任. 主要从事生物降解医用高分子材料、组织工程和药物缓释、聚乳酸和聚-己内酯产业化等方向的研究与开发工作, 发表SCI学术论文700余篇, 授权专利260余项.

    庆祝中国科学院青年创新促进会十年华诞.
  • 基金资助:
    国家自然科学基金(51973215); 国家自然科学基金(52003268); 国家自然科学基金(51829302); 国家自然科学基金(51833010); 中国科学院青年创新促进会(2020232)

Macromolecular Effects in Medicinal Chemistry

Jiayu Zhaoa,b, Wantong Songa,c(), Zhaohui Tanga,b,c, Xuesi Chena,b,c   

  1. a Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry Chinese Academy of Sciences, Changchun 130022, China
    b University of Science and Technology of China, Hefei 230026, China
    c Jilin Biomedical Polymers Engineering Laboratory, Changchun 130022, China
  • Received:2021-12-30 Published:2022-04-28
  • Contact: Wantong Song
  • About author:
    Dedicated to the 10th anniversary of the Youth Innovation Promotion Association, CAS.
  • Supported by:
    National Natural Science Foundation of China(51973215); National Natural Science Foundation of China(52003268); National Natural Science Foundation of China(51829302); National Natural Science Foundation of China(51833010); Youth Innovation Promotion Association CAS(2020232)

Drugs can be roughly divided into small molecule drugs (naturally extracted or chemically synthesized) and macromolecular drugs (biologics) according to molecular weight. Although small molecule drugs are still the mainstay of drug research and development (R&D) at present, the slow update rate of small molecule libraries has retained their R&D speed, thus highlighting the increasingly important position of macromolecular drugs in the future pharmaceutical market. In addition to macromolecular biologics, chemically synthesized macromolecular drugs prepared by combining small molecule drugs with natural or synthetic macromolecules have received more and more attention in recent years. Due to the unique characteristic of abundant backbone architectures and spatial framework of macromolecules, including their distinctive backbone effect and multivalent effect, as well as aggregation effect and targeting effect produced by molecular assembly, many new possibilities will be introduced into the design of medicinal chemistry. In view of this, this review will briefly introduce macromolecular effects in medicinal chemistry design, with an emphasis on new performances and functions introduced in drug design based on the backbone effects, multivalent effects, aggregation effects, and targeting effects of synthetic macromolecules. We hope this review could promote the development of chemically synthesized macromolecular drugs and provide new horizons for medicinal chemistry design.

Key words: medicinal chemistry, macromolecular effect, backbone effect, multivalent effect, aggregation effect, targeting effect